Millennium Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-714,100
Closed -$7.33M – 6840
2023
Q2
$7.33M Sell
714,100
-40,000
-5% -$408K ﹤0.01% 2318
2023
Q1
$7.63M Sell
754,100
-47,500
-6% -$478K ﹤0.01% 2222
2022
Q4
$8.01M Hold
801,600
– – ﹤0.01% 2372
2022
Q3
$7.8M Sell
801,600
-76,028
-9% -$739K ﹤0.01% 2456
2022
Q2
$8.5M Hold
877,628
– – 0.01% 2242
2022
Q1
$8.53M Sell
877,628
-23,972
-3% -$232K ﹤0.01% 2323
2021
Q4
$8.84M Sell
901,600
-1,289
-0.1% -$12.6K ﹤0.01% 2281
2021
Q3
$8.88M Buy
+902,889
New +$8.92M 0.01% 2225

Millennium Management's DALS Position: Q3 2023 in Review

Millennium Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 714,100 shares — an estimated $7.33M sold.

Millennium Management first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $8.88M in Q3 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Millennium Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 714,100 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $7.33M.
  • Millennium Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 8 quarters.
  • Millennium Management's DA32 Life Science Tech Acquisition Corp position peaked at $8.88M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.